Friday, 16 April 2004 | ||
Organiser | J.G.J. van de Winkel (Utrecht, The Netherlands) | |
Sponsors | Genmab (Utrecht, The Netherlands) | |
Immune-intervention for cancer and inflammation |
||
Friday morning | ||
Chairs | J.G.J. van de Winkel (Utrecht, The Netherlands) | Abstract number |
08.30 – 08.50 | Resolution of psoriasis upon blockade of interleukin-15 biological activity in a xenograft mouse model L.S. Villadsen, J. Schuurman, F. Beurskens, T.N. Dam, F. Dagnaes-Hansen, L. Skov, J. Rygaard, M.M. Voorhorst-Ogink, M.A. van Dijk, P.W.H.I. Parren, O. Baadsgaard, and J.G.J. van de Winkel (Copenhagen, Denmark; Utrecht, The Netherlands; Aarhus, Denmark) |
217 |
08.50 – 09.30 | Cytokines as targets for immunotherapy of inflammation F. Breedveld (Leiden, The Netherlands) |
|
09.30 – 09.50 | Immunoglobulin A Fc Receptor (Fc RI) as target for antibody immunotherapy M.A. Otten, E. Rudolph, C.W. Tuk, R.M. Reijmers, R.H.J. Beelen, J.G.J. van de Winkel, and M. van Egmond (Utrecht, The Netherlands; Amsterdam, The Netherlands) |
218 |
09.50 – 10.00 | discussion | |
10.00 – 11.15 | coffee break + plenary lecture | |
11.30 – 12.10 | CpG ODN and cancer therapy G. Hartmann (Munich, Germany) |
|
12.10 – 12.30 | Expression of membrane-anchored anti Fc?RI sFv triggers effector functions in vitro, and reduces tumorogenicity in human Fc?RI expressing mice L. Bevaart, J.H.M. Jansen, L. Vitale, J. Goldstein, M.J. van Vugt, J.H.W. Leusen, J.G.J. van de Winkel, and T. Keler (Utrecht, The Netherlands; Bloomsbury, NJ, USA) |
219 |
12.30 – 12.50 | Mode of action of a novel fully human anti-EGF receptor monoclonal antibody for cancer therapy W.K. Bleeker, J.J. Lammerts v Bueren, H.H.v Ojik, A.F. Gerritsen, M. Pluyter, M. Houtkamp, J. Schuurman, M.A. v Dijk, J.G.J. vd Winkel, and P.W.H.I. Parren (Utrecht, The Netherlands) |
220 |
12.50 – 13.10 | Morphological and immunological reactions by radio-frequency ablation of the VX2 hepatoma in rabbits D. Neureiter, J. Hänsler, Th. T. Wissniowski, M. Wasserburger, S. Stintzing, M. Frieser, S. Schaber, B. Esslinger, R. Voll, D. Strobel, E. G. Hahn, D. Schuppan, and Th. Kirchner (Erlangen-Nuremberg, Germany) |
221 |
13.00 | end of workshop |